{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T12:42:14Z","timestamp":1765370534353},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T00:00:00Z","timestamp":1728604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T00:00:00Z","timestamp":1728604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-024-03902-x","type":"journal-article","created":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T06:01:36Z","timestamp":1728626496000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Combination of low-dose, long-term immunoglobulin and mirtazapine is effective in progressive multifocal leukoencephalopathy caused by JC virus infection"],"prefix":"10.1186","volume":"24","author":[{"given":"Jingjing","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhua","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shihui","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinsheng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,11]]},"reference":[{"key":"3902_CR1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41582-020-00427-y","volume":"17","author":"I Cortese","year":"2021","unstructured":"Cortese I, Reich DS, Nath A. Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease. Nat Rev Neurol. 2021;17:37\u201351.","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"3902_CR2","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/fcp.12247","volume":"31","author":"O Colin","year":"2017","unstructured":"Colin O, Favreli\u00e8re S, Quillet A, Neau JP, Houeto JL, Lafay-Chebassier C, et al. French Pharmacovigilance Network. Drug-induced progressive multifocal leukoencephalopathy: a case\/ noncase study in the French pharmacovigilance database. Fundam Clin Pharmacol. 2017;31(2):237\u201344.","journal-title":"Fundam Clin Pharmacol"},{"key":"3902_CR3","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1136\/jnnp.2006.092353","volume":"77","author":"S Vulliemoz","year":"2006","unstructured":"Vulliemoz S, Lurati-Ruiz F, Borruat FX, Delavelle J, Koralnik IJ, Kuntzer T, et al. Favourable outcome of progressive multifocal leucoencephalopathy in two patients with dermatomyositis. J Neurol Neurosurg Psychiatry. 2006;77:1079\u201382.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3902_CR4","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s00415-018-9140-0","volume":"266","author":"N Sanjo","year":"2019","unstructured":"Sanjo N, Nose Y, Shishido-Hara Y, Mizutani S, Sekijima Y, Aizawa H, et al. A controlled inflammation and a regulatory immune system are associated with more favorable prognosis of progressive multifocal leukoencephalopathy. J Neurol. 2019;266:369\u201377.","journal-title":"J Neurol"},{"key":"3902_CR5","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1136\/jnnp-2017-316886","volume":"89","author":"MP Wattjes","year":"2018","unstructured":"Wattjes MP, Wijburg MT, van Eijk J, Frequin S, Uitdehaag BMJ, Barkhof F, et al. Inflammatory natalizumab-associated PML: baseline characteristics, lesion evolution and relation with PML-IRIS. J Neurol Neurosurg Psychiatry. 2018;89:535\u201341.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3902_CR6","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.3899\/jrheum.111126","volume":"39","author":"M Dastmalchi","year":"2012","unstructured":"Dastmalchi M, Laki J, Lundberg IE, Iacobaeus E. Progressive multifocal leukoencephalopathy in a patient with polymyositis: case report and literature review. J Rheumatol. 2012;39:1299\u2013303.","journal-title":"J Rheumatol"},{"issue":"7","key":"3902_CR7","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1002\/art.22657","volume":"56","author":"LH Calabrese","year":"2007","unstructured":"Calabrese LH, Molloy ES, Huang D, Ransohoff RM. Progressive multifocal leukoencephalopathy in rheumatic diseases: evolving clinical and pathologic patterns of disease. Arthritis Rheum. 2007;56(7):2116\u201328.","journal-title":"Arthritis Rheum"},{"key":"3902_CR8","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1111\/j.1468-1331.2006.01362.x","volume":"13","author":"W K\u00fcker","year":"2006","unstructured":"K\u00fcker W, Mader I, N\u00e4gele T, Uhl M, Adolph C, Klose U, et al. Progressive multifocal leukoencephalopathy: value of diffusion-weighted and contrast-enhanced magnetic resonance imaging for diagnosis and treatment control. Eur J Neurol. 2006;13:819\u201326.","journal-title":"Eur J Neurol"},{"key":"3902_CR9","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1093\/brain\/awab419","volume":"145","author":"LE Baldassari","year":"2022","unstructured":"Baldassari LE, Wattjes MP, Cortese ICM, Gass A, Metz I, Yousry T, et al. The neuroradiology of progressive multifocal leukoencephalopathy: a clinical trial perspective. Brain. 2022;145:426\u201340.","journal-title":"Brain"},{"key":"3902_CR10","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1212\/WNL.0b013e3182a43e6d","volume":"81","author":"G Martin-Blondel","year":"2013","unstructured":"Martin-Blondel G, Bauer J, Cuvinciuc V, Uro-Coste E, Debard A, Massip P, et al. In situ evidence of JC virus control by CD8\u2009+\u2009T cells in PML-IRIS during HIV infection. Neurology. 2013;81:964\u201370.","journal-title":"Neurology"},{"issue":"16","key":"3902_CR11","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1212\/WNL.0000000000207622","volume":"101","author":"F Schweitzer","year":"2023","unstructured":"Schweitzer F, Laurent S, Cortese I, Fink GR, Silling S, Skripuletz T, et al. Progressive Multifocal Leukoencephalopathy: Pathogenesis, Diagnostic tools, and potential biomarkers of response to Therapy. Neurology. 2023;101(16):700\u201313.","journal-title":"Neurology"},{"key":"3902_CR12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s13365-023-01114-6","volume":"29","author":"B Cifci","year":"2023","unstructured":"Cifci B, Yildiz Y, Altin E, Habibi H, Kocer B, Dizbay M. Successful treatment of HIV-associated progressive multifocal leukoencephalopathy (PML) with mirtazapine, mefloquine, and IVIG combination therapy: a case report. J Neurovirol. 2023;29:111\u20135.","journal-title":"J Neurovirol"},{"issue":"6","key":"3902_CR13","doi-asserted-by":"publisher","first-page":"e618","DOI":"10.1212\/NXI.0000000000000618","volume":"6","author":"P Anand","year":"2019","unstructured":"Anand P, Hotan GC, Vogel A, Venna N, Mateen FJ. Progressive multifocal leukoencephalopathy: a 25-year retrospective cohort study. Neurol Neuroimmunol Neuroinflamm. 2019;6(6):e618.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"3902_CR14","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1126\/science.1103492","volume":"306","author":"GF Elphick","year":"2004","unstructured":"Elphick GF, Querbes W, Jordan JA, Gee GV, Eash S, Manley K, et al. The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science. 2004;306:1380\u201383.","journal-title":"Science"},{"issue":"1","key":"3902_CR15","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/antib12010020","volume":"12","author":"T Velikova","year":"2023","unstructured":"Velikova T, Sekulovski M, Bogdanova S, Vasilev G, Peshevska-Sekulovska M, Miteva D, et al. Intravenous immunoglobulins as Immunomodulators in Autoimmune diseases and Reproductive Medicine. Antibodies (Basel). 2023;12(1):20.","journal-title":"Antibodies (Basel)"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-024-03902-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-024-03902-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-024-03902-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T18:01:36Z","timestamp":1728669696000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-024-03902-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,11]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3902"],"URL":"https:\/\/doi.org\/10.1186\/s12883-024-03902-x","relation":{},"ISSN":["1471-2377"],"issn-type":[{"type":"electronic","value":"1471-2377"}],"subject":[],"published":{"date-parts":[[2024,10,11]]},"assertion":[{"value":"18 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of the first affiliated hospital of Sun Yat-sen University (No. [2023]669).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of their clinical details and\/or clinical images was obtained from the patient\/participant.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"384"}}